Advanced Therapy Medicinal Product (ATMP) Compliance: Human-Centric Challenges and Strategies

atmps

Introduction Advanced Therapy Medicinal Products (ATMPs) represent a revolutionary class of treatments encompassing gene therapy, somatic cell therapy, and tissue-engineered products. These therapies offer unprecedented potential to treat complex diseases but have unique manufacturing challenges requiring stringent regulatory oversight. The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have implemented rigorous … Read more

Video from MD&M in Anaheim

Last week at MDM W 2025 in Anaheim, CA, we connected with industry leaders in medical devices, industrial automation, packaging, and contract manufacturing. Meeting with top custom equipment builders worldwide, we explore turnkey validation solutions that streamline automation and compliance.  

Validation University 2025

You are invited to a healthcare conference: Keynote Speaker – Dr. David Vincent, MPH, PhD (Chief Scientific Officer) Risk-Based Facility Qualification in Multi-Product & Multi-Use Facilities Date: March 26th – 27th, 2024 (Philadelphia, PA) click on image for more information

Current FDA 483s and Warning Letters Trends in Pharmaceutical, Biotechnology, and Medical Device Industries

handful of pills

The pharmaceutical, biotechnology, and medical device industries operate under rigorous regulatory oversight to ensure public safety, product efficacy, and consistent quality. The Food and Drug Administration (FDA) plays a pivotal role in this oversight in the United States, particularly through Good Manufacturing Practices (GMPs). Despite stringent internal controls and monitoring systems, these industries frequently receive … Read more

Current Industry Trends Impacting Cleaning Validation

Current Industry Trends Impacting Cleaning Validation

By David W, Vincent, CSO, B.Sc., MPH, PhD Introduction Cleaning validation ensures that pharmaceutical manufacturing equipment is effectively cleaned to prevent cross-contamination of drug products, ensuring product safety and quality. It is an ongoing process requiring robust initial validation, routine monitoring, and continuous improvement to meet regulatory standards. This article explores the latest trends in … Read more

VTI Life Sciences, Inc. is honored to announce its registration with The AABC Commissioning Group (ACG)

AABC Commissioning Group

  VTI Life Sciences, Inc. is honored to announce its registration with The AABC Commissioning Group (ACG), a distinguished non-profit association committed to advancing independent, third-party commissioning professionals. This prestigious registration underscores our dedication to quality and industry standards. Our registration with ACG involves obtaining the Certified Commissioning Authority (CxA) certification, a mark of excellence … Read more

Automation Process Validation: The Key to Increasing Productivity and Improving Quality

Automation Process Validation

By Cesar Lucero, M.S.c (AI Technology) VTI Life Sciences Lead Automation Engineer Introduction In production environments, time is of the essence and quality is non-negotiable. Companies still using manual processes and human inspections face significant challenges such as fatigue, decreasing attention spans, and variability between operators. These issues are further compounded by shifts, staff rotation, … Read more

Current Trends in Environmental Monitoring: Impact of Recent FDA and EMA Findings on Companies and Preventative Measures

Environmental monitoring (EM) in life sciences manufacturing is a cornerstone of contamination control, designed to ensure that products meet the highest standards of sterility and quality. As regulatory expectations evolve, agencies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are increasingly emphasizing risk-based approaches and advanced technologies in their … Read more

Twitter
LinkedIn
LinkedIn
Share